Technical Articles

Apoptosis evasion
基于BCL-XL/CRBN PROTAC试剂盒开发的新型BCL-XL降解剂增强BCL-2抑制功能的研究
Study on Novel BCL-XL Degraders Developed Based on BCL-XL/CRBN PROTAC Kits to Enhance BCL-2 Inhibitory Function
发布时间 2026-01-06
Evasion of apoptosis is a hallmark of cancer, often involving an imbalance between pro-apoptotic and anti-apoptotic proteins (such as BCL-2 family proteins).
View details
  • Cancer
  • BCL-XL/CRBN PROTAC Kit
  • Apoptosis evasion
  • Anti-apoptotic protein
Total 1
  • 1
Go to
UA
Link：
Products
Application
Cell FactorTarget Proteins
Custom Services
Custom Protein Expression ServicesCustom SPR Services
About Us
PromotionTechnical ArticlesProduct ApplicationFAQsCitationsAbout Us
We Media：
Facebook Linkedin YouTube X Thraeds Pinterest
©2021-2026 all rights reserved UA Biotechnology Co.,Ltd.
Privacy Policy
网站备案号 浙ICP备2022019033号-2 浙公网安备33010202004867号
 Business license (three certificates in one)
Tel：+86-25-56221161
E-mail：order@ua-bio.com
All products sold on this website shall not be used for clinical diagnosis or treatment of humans or animals, and shall only be used for non-medical purposes such as industrial or scientific research.